Evaluation of the Clinical Efficacy and Mechanisms of Cord Plasma Eye Drops in the Treatment of Neuropathic Corneal Pain

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1Since this trial is using cord plasma eye drops — a treatment made from umbilical cord blood — what do we know so far about its safety profile for use directly on the eye, and are there any risks I should be aware of before considering it?
2. 2The trial measures my pain using something called the Ocular Pain Assessment Survey — how will my responses on that questionnaire actually influence my treatment during the study, and what happens if my pain gets significantly worse while I'm enrolled?
3. 3This trial also uses in vivo confocal microscopy to look at the nerves in my cornea — is that imaging process itself safe and comfortable, and would those results give me useful information about my condition beyond the study?
4. 4Since this is listed as Phase NA, meaning it may be exploratory or early-stage, does that mean there's less established evidence about whether cord plasma eye drops actually work for neuropathic corneal pain compared to treatments that have gone through standard phase trials?
5. 5Are there any existing or standard treatments for neuropathic corneal pain — like autologous serum eye drops or other nerve-targeted therapies — that I should try first before considering an experimental approach like this one?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.